TTrialPathMatch Me to Trials
← Back to trials
RecruitingDiabetes Mellitus Type 2

Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric Surgery

Eligible age

18–65 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The present protocol aims to understand and establish whether there is a causal link between adipose tissue metabolic remodeling and Type 2 Diabetes (T2D) remission after bariatric surgery. All participants will have a bariatric surgery, divided in 2 groups: with or without T2D.

Sponsor: Université de Sherbrooke

You may qualify if…

  • ✓ Aged 18 to 65
  • ✓ BMI 35 kg/m2
  • ✓ Diagnosed T2D - according to Diabetes Canada diagnostics criteria.
  • ✓ Diagnosed non-T2D - according to Diabetes Canada diagnostics criteria.
  • ✓ Women with a negative serum pregnancy test.

You may not qualify if…

  • ✕ Treatment with an oral contraceptive;
  • ✕ Treatment with fibrate, thiazolidinedione, insulin, or beta-blocker, drugs that affect metabolism and cannot be stopped temporarily or which have long-lasting effects;
  • ✕ Presence of overt cardiovascular disease, liver or renal failure or other uncontrolled medical conditions;
  • ✕ Any other contraindication to surgery or to temporarily suspending current medications for diabetes, lipids or hypertension;
  • ✕ Smoking or consumption of more than 2 alcoholic beverages per day;
  • ✕ Any contraindication to MRI;
  • ✕ A Diabetes Remission (DiaRem) score \>8 (low probability of T2D remission);
  • ✕ Having participated to a research study with exposure to radiation in the last two years before the start of the study;

Source: ClinicalTrials.gov · NCT05934409 · last updated 2026-02-10

Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac M · TrialPath